PT1151007E - Metodo para produzir uma preparacao com base em fibrinogenio e fibronectina assim como composicoes proteicas obteniveis de acordo com este metodo - Google Patents

Metodo para produzir uma preparacao com base em fibrinogenio e fibronectina assim como composicoes proteicas obteniveis de acordo com este metodo

Info

Publication number
PT1151007E
PT1151007E PT00906319T PT00906319T PT1151007E PT 1151007 E PT1151007 E PT 1151007E PT 00906319 T PT00906319 T PT 00906319T PT 00906319 T PT00906319 T PT 00906319T PT 1151007 E PT1151007 E PT 1151007E
Authority
PT
Portugal
Prior art keywords
fibronectin
fibrinogen
protein compositions
producing
obtained according
Prior art date
Application number
PT00906319T
Other languages
English (en)
Inventor
Thomas Seelich
Broermann Ralf
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of PT1151007E publication Critical patent/PT1151007E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT00906319T 1999-02-12 2000-02-10 Metodo para produzir uma preparacao com base em fibrinogenio e fibronectina assim como composicoes proteicas obteniveis de acordo com este metodo PT1151007E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT20699 1999-02-12
US09/502,029 US6579537B2 (en) 1999-02-12 2000-02-10 Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine

Publications (1)

Publication Number Publication Date
PT1151007E true PT1151007E (pt) 2006-07-31

Family

ID=25591856

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00906319T PT1151007E (pt) 1999-02-12 2000-02-10 Metodo para produzir uma preparacao com base em fibrinogenio e fibronectina assim como composicoes proteicas obteniveis de acordo com este metodo

Country Status (12)

Country Link
US (2) US6579537B2 (pt)
EP (1) EP1151007B1 (pt)
JP (1) JP2007131638A (pt)
AT (1) ATE325133T1 (pt)
AU (2) AU774118B2 (pt)
CA (1) CA2362513C (pt)
DE (1) DE60027695T2 (pt)
DK (1) DK1151007T3 (pt)
ES (1) ES2263451T3 (pt)
PT (1) PT1151007E (pt)
SI (1) SI1151007T1 (pt)
WO (1) WO2000047621A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物
US8428685B2 (en) * 2001-09-05 2013-04-23 Given Imaging Ltd. System and method for magnetically maneuvering an in vivo device
US20050221035A1 (en) * 2004-04-01 2005-10-06 Derek Wyatt Method for reducing freeze-thaw voids in uncured adhesives
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20070231362A1 (en) * 2006-04-04 2007-10-04 3M Innovative Properties Company Schistose microfibrillated article for cell growth
US20070238167A1 (en) 2006-04-04 2007-10-11 3M Innovative Properties Company Flat microfibers as matrices for cell growth
WO2008089466A2 (en) * 2007-01-18 2008-07-24 Baxter International Inc. Fibrin gel for controlled release of tgf-beta and uses thereof
CA2691024A1 (en) 2007-06-19 2008-12-24 Baxter Healthcare S.A. Fibrin gel for controlled release of pdgf and uses thereof
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
WO2010006219A2 (en) * 2008-07-09 2010-01-14 Baxter International Inc. Use of scaffold comprising fibrin for delivery of stem cells
CN102448505B (zh) * 2009-05-28 2015-04-15 埃得生物公司 多层蛋白质膜、制造方法以及使用该膜的药物递送装置和生物医学植入物
CN102781464A (zh) 2010-01-08 2012-11-14 巴克斯特国际公司 用于吸引并保持再生和修复细胞的生物基质
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
BR112013006384B1 (pt) * 2010-09-20 2021-12-07 Octapharma Ag Processo para purificar fibrinogênio a partir de uma fonte contendo fibrinogênio, produto de fibrinogênio e uso de uma resina de troca aniônica
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
ES2642383T3 (es) 2012-03-13 2017-11-16 Octapharma Ag Procedimiento mejorado de producción de fibrinógeno y fibrinógeno producido por el mismo
US11071805B2 (en) 2013-04-22 2021-07-27 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patches
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
CA2994959A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
CN108697829B (zh) 2015-10-19 2021-06-11 西兰丁姆医疗公司 改进的基于纤维蛋白原的组织粘合贴片
US11471556B2 (en) 2015-10-19 2022-10-18 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patch
CN105617451A (zh) * 2016-02-29 2016-06-01 苏州市贝克生物科技有限公司 壳聚糖基止血材料及其制备方法
CN105770970A (zh) * 2016-02-29 2016-07-20 苏州市贝克生物科技有限公司 复合多糖止血薄膜及其制备方法
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN108017710B (zh) * 2018-01-19 2020-02-04 贵州泰邦生物制品有限公司 一种人纤维蛋白原的制备方法
EP4017511A4 (en) * 2019-08-22 2023-07-12 Awidi, Abdalla S. METHOD FOR PREPARING A FIBRIN-FREE PLATELET LYSAT AND USES OF THE SAME METHOD
CA3224328A1 (en) 2021-08-13 2023-02-16 Biotest Ag Fibrinogen compositions and methods of preparation
WO2023119265A1 (en) 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Fibrinogen comprising formulation and uses thereof
ES2957484A1 (es) 2022-06-07 2024-01-19 Santxa Res S L U Gel de fibrina y método de obtención del mismo

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
DE3203775A1 (de) 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
JPH0199565A (ja) * 1987-10-12 1989-04-18 Green Cross Corp:The フィブリン糊調製用キット
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
WO1992013495A1 (en) * 1991-02-07 1992-08-20 Fibratek, Inc. Fibrinogen based adhesive
JPH04347162A (ja) * 1991-05-23 1992-12-02 Japan Synthetic Rubber Co Ltd 生体組織接着剤
AT402891B (de) 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
US5288853A (en) * 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
EP0674531A1 (de) 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
US5395923A (en) 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5330974A (en) 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
AT402788B (de) 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
HRP940645A2 (en) 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
AT406019B (de) 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate
DE19617369A1 (de) 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
AT407117B (de) 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物

Also Published As

Publication number Publication date
JP2007131638A (ja) 2007-05-31
AU774118B2 (en) 2004-06-17
DE60027695D1 (de) 2006-06-08
ES2263451T3 (es) 2006-12-16
US7241603B2 (en) 2007-07-10
US6579537B2 (en) 2003-06-17
WO2000047621A1 (en) 2000-08-17
CA2362513C (en) 2011-04-26
US20020172718A1 (en) 2002-11-21
AU2804100A (en) 2000-08-29
EP1151007A1 (en) 2001-11-07
DK1151007T3 (da) 2006-09-04
AU2004201982A1 (en) 2004-06-03
US20030077270A1 (en) 2003-04-24
AU2004201982B2 (en) 2007-12-06
EP1151007B1 (en) 2006-05-03
ATE325133T1 (de) 2006-06-15
CA2362513A1 (en) 2000-08-17
DE60027695T2 (de) 2007-04-26
SI1151007T1 (sl) 2006-10-31

Similar Documents

Publication Publication Date Title
PT1151007E (pt) Metodo para produzir uma preparacao com base em fibrinogenio e fibronectina assim como composicoes proteicas obteniveis de acordo com este metodo
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
DE60230274D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
ATE368689T1 (de) Neodymium-carboxylatederivate und ihre verwendung für die polymerisation von konjugierten dienen
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
ATE446313T1 (de) Muteine von tränen-lipocalin
ATE218154T1 (de) Physikalisch modifizierte abbaubare thermoplastische zusammensetzung
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
DE50005037D1 (de) Verfahren zur herstellung von unterbekleidungsstücken mittels klebeverbindung
ATE453622T1 (de) Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
BG111461A (en) TECHNICAL METHOD FOR OBTAINING TROPENOL
DE602006016915D1 (de) Embolisierung unter verwendung von poly-4-hydroxybutyrat-partikeln
BRPI0515974A (pt) poliésteres amorfos, insaturados, modificados, endurecìveis por radiação
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
ES2113878T3 (es) Proteina c hibrida.
ATE461934T1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-car onsäure -lacton und schlüsselzwischenprodukte für dieses verfahren
DE50302888D1 (de) Verfahren zur herstellung reiner thioctsäure
ATE451108T1 (de) Verfahren zur behandlung von verletzungen des nervensystems in verbindung mit einer blutung
DE60313157D1 (de) Ein verfahren zur herstellung von clopidogrel
ES2116513T3 (es) Procedimiento para la preparacion de derivados de eritro-3-amino-1,2-epoxidos opticamente activos.
ATE236895T1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
DE50202431D1 (de) Verfahren zum herstellen von neuen spinosyn-derivaten
ATE315549T1 (de) Verfahren zur herstellung von trifluorethoxysubstituierten benzoesäuren
BR0207757A (pt) Método para produzir uma composição de pantotenato secável por pulverização isenta de beta-alanina, e, composição de pantotenato secável por pulverização
BR0214531A (pt) Processo para reduzir a toxidade de pelo menos um Ènio-composto em uma solução aquosa, e respectiva solução aquosa